期刊文献+

2型糖尿病患者血清LDL-C CysC水平与动脉粥样硬化的相关性分析 被引量:6

The relationship between levels of LDL-C、CysC and Atherosclerosis in patients with type 2 diabetes mellitus
下载PDF
导出
摘要 目的探讨2型糖尿病(T2DM)患者血清低密度脂蛋白胆固醇(LDL-C)、胱抑素C(Cys C)与动脉粥样硬化(AS)的相关性。方法选择2014年6月—2016年6月我院内分泌科住院的T2DM患者228例,根据颈动脉内膜中膜厚度(IMT)分为非AS组(n=79)和AS组(n=149),对AS的相关危险因素进行分析。结果单因素分析示,非AS组和AS组2组间LDL-C、Cys C、总胆固醇(TC)、甘油三脂(TG)、年龄、收缩压间差异有统计学意义(P<0.05);多因素Logistic回归分析示,LDL-C、Cys C、年龄及收缩压是T2DM并AS的独立危险因素(P<0.05)。结论 LDL-C与Cys C水平是T2DM并AS的独立危险因素。 Objective To observe the relationship between levels of low density lipoprotein cholesterol(LDL-C),Cystatin C(Cys C)and Atherosclerosis(AS)in patients with type 2 diabetes mellitus(T2DM).Methods 228 cases with T_2DM were selected to the endocrinology department of our hospital from June 2014 to June 2016. According to the carotid intima-media thickness(IMT),patients were divided into two groups:non-AS group(n=79)and AS group(n=149).A multi-factor Logistic regression was performed to analyze the risk factors associated with the incidence of T_2DM complicated with AS.Results(1)Univariate analysis showed that the incidence of AS was associated with Cys C,LDL-C,TC,TG,age,systolic blood pressure(P〈0.05);(2)Multi-factor Logistic regression indicated that LDL-C,Cys C,systolic blood pressure and age were the independent risk factors for the incidence of AS(P〈0.05).Conclusions It is proved that LDL-C and Cys C are the independent risk factors for the incidence of AS with T_2DM.
作者 周春亭
出处 《基层医学论坛》 2017年第14期1812-1814,共3页 The Medical Forum
关键词 2型糖尿病 动脉粥样硬化 低密度脂蛋白胆固醇 胱抑素C 颈动脉内-中膜厚度 Type 2 diabetes mellitus Atherosclerosis Low density lipoprotein cholesterol Cystatin C Intima-media thickness
  • 相关文献

参考文献3

二级参考文献25

  • 1Inker LA, Okparavero A. Cystatin C as a marker of glomerular filtration rate: prospects and limitations. Curr Opin Nephrol Hypertens, 2011320(6) :631-639.
  • 2Qutb A, Syed G, Tamim HM, et al. Cystatin C-based formula is superior to MDRD, Cockcroft-Gault and Nankivell formulae in estimating the glomerular filtration rate in renal allografts. Exp Clin Transplant, 2009 , 7 (4):197-202.
  • 3Hois R, Beve S, Ekart R, et al. Serum cystatin C-based equation compared to serum creatinine-based equations for estimation of glomerular filtration rate in patients with chronic kidney disease. Clin Nephrol, 2008 , 70(1): 10-17.
  • 4Cheng XW, Huang Z, Kuzuya M, et al. Cysteine protease cathepsins in atherosclerosis-based vascular disease and its complications. Hypertension,2011 ,58(6) :978-986.
  • 5Turner R, Cull C, Holman R. 4K prospeeteetive diabetes study 17: A nine-year update of a randomized controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med, 1996;124(1 Pt 2):134.
  • 6Koenig W, Twardella D, Brenner H, et al. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events:more than simply a marker of glomerular filtration rate. Clin Chem,2005, 51(2):321-327.
  • 7Eriksson P, Deguchi H, SamnegardA, et al.Human evidence that the cystatin c gene is implicated in focal progression of coronary artery disease. Atheroscler Thromb Vasc Biol,2004,24(3):551-557.
  • 8Urbonavieiene G, Shi GP, Urbonavicius S, et al. Higher cystatin C level predicts long-term mortality in patients with peripheral arterial disease. Atheroselerosis, 2011 ; 216 (2) : 440- 445.
  • 9Turk V, Stoka V, Turk D. Cystatins: biochemical and structural properties, and medical relevance. Front Biosci,2008,1(13):5406-5420.
  • 10Cimerman N, Brgu PM, Krasovec M, etal. Serum cystatin C, a potent inhibitor of cysteine proteinases is elevated in asthmatic patients. Clin Chim Acta,2000,300(1-2) :83-95.

共引文献107

同被引文献61

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部